Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Athiam 100mg tablets
0906026M0BJAAAG
|
Athiam | Thiamine hydrochloride | Nutrition and Blood | 2 |
|
Atomoxetine 20mg/5ml oral suspension
0404000S0AAALAL
|
Atomoxetine hydrochloride | Atomoxetine hydrochloride | Central Nervous System | 2 |
|
Atropine 1mg/1ml solution for injection ampoules
1501030D0AAARAR
|
Atropine sulfate (Parenteral) | Atropine sulfate | Anaesthesia | 2 |
|
Atropine 600microgram tablets
0102000ACAAAGAG
|
Atropine sulfate (Oral) | Atropine sulfate | Gastro-Intestinal System | 2 |
|
Avoca 75% silver nitrate applicators with thick handles
1307000Q0BBAGAC
|
Avoca | Silver nitrate | Skin | 2 |
|
Azathioprine 30mg/5ml oral liquid
0802010G0AABCBC
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 2 |
|
Azathioprine 75mg/5ml oral liquid
0802010G0AAATAT
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 2 |
|
Bapscarcare S sheet 15cm x 20cm rectangular
20031300075
|
Bapscarcare S sheet 15cm x 20cm rectangular | Wound Management & Other Dressings | Dressings | 2 |
|
Baricitinib 2mg tablets
1001030ACAAABAB
|
Baricitinib | Baricitinib | Musculoskeletal and Joint Diseases | 2 |
|
Beclometasone 50micrograms/dose inhaler
0302000C0AAAAAA
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 2 |
|
Bedranol 160mg tablets
0204000R0BDAHAL
|
Bedranol | Propranolol hydrochloride | Cardiovascular System | 2 |
|
Beechams All-In-One oral solution
0407010X0BTACBA
|
Beechams (Paracetamol combined) | Paracetamol combined preparations | Central Nervous System | 2 |
|
Benadryl Allergy 1mg/ml oral solution
0304010I0BEACAB
|
Benadryl | Cetirizine hydrochloride | Respiratory System | 2 |
|
BeneFoot medical shoe original post op with toe cover male
21290000139
|
BeneFoot medical shoe original post op with toe cover male | Pressure Offloading Device | Appliances | 2 |
|
Benralizumab 30mg/1ml inj pre-filled disposable devices
0304020AAAAABAB
|
Benralizumab | Benralizumab | Respiratory System | 2 |
|
Berinert 500unit inj vials
0304030F0BDAAAA
|
Berinert | C1-Esterase inhibitor | Respiratory System | 2 |
|
Betamethasone valerate 0.1% cream 25% in Coal tar paste
1304000F0AAEQEQ
|
Betamethasone valerate (Topical) | Betamethasone valerate | Skin | 2 |
|
Betnovate-C ointment
1304000F0BBAMCD
|
Betnovate (Topical) | Betamethasone valerate | Skin | 2 |
|
Bictegravir 50mg /Emtr 200mg /Tenofovir alafenamide 25mg tab
0503010AQAAAAAA
|
Bictegravir/emtricitabine/tenofovir alafenamide | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 2 |
|
BioBag larvae sterile
1311070S0BCABAA
|
Ster Larvae (Biobags) | Ster larvae | Skin | 2 |
|
BioGaia Pharax Kids Probiotic oral drops
0913531A0BEACAF
|
BioGaia liquid OTC probiotic | Liquid OTC probiotic (0913531) | Nutrition and Blood | 2 |
|
Biosorb Gelling Fibre dressing 2cm x 45cm ribbon
20031700256
|
Biosorb Gelling Fibre dressing 2cm x 45cm ribbon | Wound Management & Other Dressings | Dressings | 2 |
|
Bioteque America gellhorn pessary size 3, 57mm diameter, silicone, short stem
21011200363
|
Bioteque America gellhorn pessary size 3, 57mm diameter, silicone, short stem | Other Appliances | Appliances | 2 |
|
Bioteque America gellhorn pessary size 3, 57mm diameter, silicone, standard stem
21011200354
|
Bioteque America gellhorn pessary size 3, 57mm diameter, silicone, standard stem | Other Appliances | Appliances | 2 |
|
Bioteque America gellhorn pessary size 4, 64mm diameter, silicone, short stem
21011200364
|
Bioteque America gellhorn pessary size 4, 64mm diameter, silicone, short stem | Other Appliances | Appliances | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.